1 the applicant, csl limited ("csl"), seeks an interlocutory injunction to restrain the respondent, glaxosmithkline australia pty ltd ("gska"), from making certain representations concerning gardasil, a vaccine marketed by csl, and cervarix, a vaccine which gska hopes to market in australia in the near future.
there was nothing to suggest that any irreparable harm had been done by anything said to any doctor by a gska representative.
the issue is discussed in meagher, gummow &amp; lehane (at [21-395]), and need not be further canvassed here.